RAB2B, a member of the Rab family containing a conserved GTP-binding domain and variable N-terminal and C-terminal domains [22, 26], has been characterized as a protooncogene dysregulated in a variety of tumors and critical for tumor development [23, 27], showing a gradual decrease in expression with improvement of disease [28]. Here, RAB2B is linked to neoplasm.